Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the
...Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration pursuant to that certain Placement Agent Agreement by and between., Inmune Bio Inc., a Nevada company (the "Company") and Univest Securities, LLC, as the placement agent of
funds duly paid by the Company (the "Placement Agent"), dated [●], 20[__] (the "Placement Agent Agreement"), the Placement Agent (in such capacity with its permitted successors or
on behalf of [●] ("Holder"), assigns, the "Holder"), as registered owner of this Purchase Warrant,
to Tenon M...edical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning from [●], 2022 20[__] (the "Commencement Date"), "Exercise Date") [THE DATE THAT IS 180 DAYS AFTER THE EFFECTIVE DATE OF THE REGISTRATION STATEMENT], and at or before 5:00 p.m., Eastern time, [●], 2026 20[__] [DATE THAT IS FIVE YEARS ANNIVERSARY THEREOF] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the date hereof and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $8.00 per Share; Share (100% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. Any term not defined herein shall have the meaning ascribed thereto in the Placement Agent Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Aegis Capital Corp. ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, SOBR Safe, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________] [DATE THAT... IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [__] shares of common stock of the Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[__] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean ☑, 2022, the date on which the Registration Statement on Form S-1 (File No. 333-260681 ) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration of funds duly paid pursuant to that certain Underwriting Agreement by
or on behalf of [●] ("Holder"), and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the "Company") and WallachBeth Capital, LLC dated [*], 2022, as amended (the "Underwriting Agreement"), WallachBeth Capital, LLC ("Holder") and its assignees, as registered
owner holders of this Purchase Warrant,
to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entit
...led, at any time or from time to time beginning [●], from [*], 2022 (the "Commencement "Effective Date"), the date that is one hundred and eighty (180) days after the date of the commencement of the sales of the Company's Common Stock, $0.007 par value per share (the "Common Stock"), and at or before 5:00 p.m., Eastern time, [●], 2026 on [*], 2027 (five (5) years from the Effective Date) (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [*] shares of common stock Common Stock of the Company, par value $0.00001 per share (the "Shares"), Company (equal to two (2.0%) percent of the Common Stock sold in the Offering including any exercise of the overallotment option), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. purchase warrant ("Purchase Warrant"). This Purchase Warrant is initially exercisable at $[●] $[*] per Share; share of Common Stock (115% of the price of the Common Stock sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share share and the number of Shares shares of Common Stock to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price as set forth above or the adjusted exercise price, price as a result of the events set forth in Section 6 below, depending on the context. Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement. 1 (2.0%) of the number of shares of Common Stock sold in the Offering.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] Alexander Capital LP ("Holder"), as registered owner of this Purchase Warrant,
to Tenon Medical, SOBR Safe, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from [________________] [DATE THAT IS SIX MONTHS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 [____________] [DATE THA...T IS FIVE YEARS FROM THE EFFECTIVE DATE OF THE OFFERING] (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [__] shares of common stock of the Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $[__] per Share; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. The term "Effective Date" shall mean [ ], 2022, the date on which the Registration Statement on Form S-1 (File No. 333-260681 ) of the Company was declared effective by the Securities and Exchange Commission.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration of funds duly paid pursuant to that certain Underwriting Agreement by
or on behalf of [●] ("Holder"), and between BIOAFFINITY TECHNOLOGIES, INC., a Delaware corporation (the "Company") and WallachBeth Capital, LLC dated [*], 2022, as amended (the "Underwriting Agreement"), WallachBeth Capital, LLC ("Holder") and its assignees, as registered
owner holders of this Purchase Warrant,
to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entit
...led, at any time or from time to time beginning [●], from [*], 2022 (the "Commencement "Effective Date"), the date that is one hundred and eighty (180) days after the date of the commencement of the sales of the Company's Common Stock, $0.001 par value per share (the "Common Stock"), and at or before 5:00 p.m., Eastern time, [●], 2026 on [*], 2027 (five (5) years from the date hereof) (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] [*] shares of common stock Common Stock of the Company, par value $0.00001 per share (the "Shares"), Company (equal to five (5.0%) percent of the Common Stock sold in the Offering including any exercise of the overallotment option), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. purchase warrant ("Purchase Warrant"). This Purchase Warrant is initially exercisable at $[●] $[*] per Share; share of Common Stock (115% of the price of the Common Stock sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share share and the number of Shares shares of Common Stock to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price as set forth above or the adjusted exercise price, price as a result of the events set forth in Section 6 below, depending on the context. Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement. 1 (5%) of the number of shares of common stock sold in the Offering.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in for good and valuable consideration of funds duly paid by or on behalf of
[●] Roth Capital Partners LLC ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Eastside Distilling, Inc., a
Delaware Nevada corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from August 10, 2018 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 August 10, 2022 (the "Expiration Date"), but not
...thereafter, before the Commencement Date or after the Expiration Date, to subscribe for, purchase and receive, in whole or in part, up to [●] shares of common stock 120,000 units ("Units") of the Company, each unit consisting of one share of the Company's common stock, par value $0.00001 $0.0001 per share (the "Shares"), subject "Common Stock") and warrants in the form of Exhibit A attached hereto (the "Warrants") to adjustment as provided in Section 6 hereof. purchase one share of Common Stock. The shares of Common Stock and the Warrants (each a "Component Security" and collectively, the "Component Securities") are immediately separable and will be issued separately upon exercise of this Purchase Warrant. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $5.40 per Share; Unit; provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share Unit and the number of Shares Units to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration of funds duly paid pursuant to that certain Underwriting Agreement by
or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., and between DIGITAL BRANDS GROUP, INC., a Delaware corporation (the "Company"),
Holder on one hand, and Alexander Capital, L.P., on the other hand, dated May 5, 2022, as amended (the "Underwriting Agreement"), Alexander Capital, L.P. ("Holder") and its assignees, as registered holders of t...his Purchase Warrant, is entitled, at any time or from time to time beginning [●], from November 1, 2022 (the "Commencement "Exercise Date"), the date that is six (6) months after the effective date of the Company's Registration Statement on Form S-1 with the Securities and Exchange Commission (the "Effective Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 on May 5, 2027 (five (5) years from the Effective Date) (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 747,796 shares of common stock Common Stock of the Company, $0.0001 par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. "Common Stock"). If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. purchase warrant ("Purchase Warrant"). This Purchase Warrant is initially exercisable at $[●] $0.3250 per Share; share of Common Stock (130% of the price of the Common Stock sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share share and the number of Shares shares of Common Stock to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price as set forth above or the adjusted exercise price, price as a result of the events set forth in Section 6 below, depending on the context. 1 A date that is five years after the Effective Date of this Warrant. Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT,
pursuant to that certain Underwriting Agreement by and between Adomani, Inc., a Delaware corporation (the "Company") and Boustead Securities, LLC ("Boustead"), as representative (the "Representative") of the several underwriters listed in
consideration of funds duly paid by Schedule A thereto (the "Underwriters"), dated May 12, 2017 (the "Underwriting Agreement"), Boustead (in such capacity with its permitted successors or
on behalf of [●] ("Holder"), assigns, the "Holder"),... as registered owner of this Purchase Warrant, to Tenon Medical, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time beginning [●], 2022 from October 22, 2017 (the "Commencement "Exercise Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 April 25, 2022 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 199,659 shares of common stock of the Company, par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law or executive order to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period commencing on the date hereof and ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $6.00 per Share; Share (one hundred twenty percent (120.0%)) of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context. Any term not defined herein shall have the meaning ascribed thereto in the Underwriting Agreement.
View More
Purchase Warrant. THIS CERTIFIES THAT, in consideration of funds duly paid by or on behalf of
[●] ________________ ("Holder"), as registered owner of this Purchase Warrant, to
Tenon Medical, Advaxis, Inc., a Delaware corporation (the "Company"), Holder is entitled, at any time or from time to time
beginning [●], 2022 from March 26, 2015 (the "Commencement Date"), and at or before 5:00 p.m., Eastern time,
[●], 2026 March 26, 2019 (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive,
...in whole or in part, up to [●] _________ shares of common stock of the Company, par value $0.00001 $0.001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this the Purchase Warrant. This Purchase Warrant is initially exercisable at $[●] $3.75 per Share; Share (125% of the price of the Shares sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share and the number of Shares to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price or the adjusted exercise price, depending on the context.
View More
Purchase Warrant. THIS CERTIFIES THAT,
in consideration of funds duly paid pursuant to that certain Underwriting Agreement by
or on behalf of [●] ("Holder"), as registered owner of this Purchase Warrant, to Tenon Medical, Inc., and between DIGITAL BRANDS GROUP, INC., a Delaware corporation (the "Company"),
Holder on one hand, and Revere Securities, LLC, on the other hand, dated May 5, 2022, as amended (the "Underwriting Agreement"), Revere Securities, LLC ("Holder") and its assignees, as registered holders of thi...s Purchase Warrant, is entitled, at any time or from time to time beginning [●], from November 1, 2022 (the "Commencement "Exercise Date"), the date that is six (6) months after the effective date of the Company's Registration Statement on Form S-1 with the Securities and Exchange Commission (the "Effective Date"), and at or before 5:00 p.m., Eastern time, [●], 2026 on May 5, 2027 (five (5) years from the Effective Date) (the "Expiration Date"), but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to [●] 747,796 shares of common stock Common Stock of the Company, $0.0001 par value $0.00001 per share (the "Shares"), subject to adjustment as provided in Section 6 hereof. "Common Stock"). If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Purchase Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period ending on the Expiration Date, the Company agrees not to take any action that would terminate this Purchase Warrant. purchase warrant ("Purchase Warrant"). This Purchase Warrant is initially exercisable at $[●] $0.3250 per Share; share of Common Stock (130% of the price of the Common Stock sold in the Offering); provided, however, that upon the occurrence of any of the events specified in Section 6 hereof, the rights granted by this Purchase Warrant, including the exercise price per Share share and the number of Shares shares of Common Stock to be received upon such exercise, shall be adjusted as therein specified. The term "Exercise Price" shall mean the initial exercise price as set forth above or the adjusted exercise price, price as a result of the events set forth in Section 6 below, depending on the context. 1 A date that is five years after the Effective Date of this Warrant. Capitalized terms not defined herein shall have the meaning ascribed to them in the Underwriting Agreement.
View More
